ATBF1 Antibodies

Santa Cruz Biotechnology delivers a wide array of ATBF1 monoclonal antibodies for research focused on understanding ATBF1 protein function. ATBF1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ATBF1, or AT-rich interactive domain-containing protein 1A, is a transcription factor that plays a critical role in regulating gene expression during development and cellular differentiation. ATBF1 influences various biological processes, including cell proliferation and apoptosis, making it an important target for research in cancer and developmental biology. Understanding ATBF1 function is essential for elucidating its contributions to disease mechanisms and potential therapeutic interventions. Researchers can explore ATBF1's role in cellular processes through multiple experimental approaches using specific conjugates such as horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC). Advanced research techniques and protocols enable detailed investigation of ATBF1's molecular interactions and signaling pathways. Extensive quality standards ensure consistent and reliable experimental outcomes. Santa Cruz Biotechnology monoclonal antibodies for ATBF1 research support scientists worldwide in advancing our understanding of cellular regulation and disease mechanisms.